The tumour suppressor CCDC6 is involved in ROS tolerance and neoplastic transformation by evading ferroptosis. Issue 11 (November 2021)

• Record Type: Journal Article
• Authors: Morra, Francesco; Merolla, Francesco; Zito Marino, Federica; Catalano, Rosaria; Franco, Renato; Chieffi, Paolo; Celetti, Angela
• Is Part Of: Heliyon. Volume 7:Issue 11(2021)
• Publication Date: 2021-11
• Subjects: Seminoma -- Embryonal carcinoma -- DNA DSBs -- Homologous recombination -- PARP inhibitors -- Deferoxamine -- Ferrostatin-1 -- xCT/SLC7A11 cystine antiporter -- Erastin -- Targeted therapies -- Glutathione; Research -- Periodicals; Medical sciences -- Periodicals; Natural history -- Periodicals; Social sciences -- Periodicals; Earth sciences -- Periodicals; Physical sciences -- Periodicals; 507.2
• DOI: 10.1016/j.heliyon.2021.e08399
• Languages: English
• ISSNs: 2405-8440

Abstract

Abstract: Coiled-coil domain containing 6 (CCDC6) is a tumour suppressor gene involved in apoptosis and DNA damage response. CCDC6 is known to be functionally impaired upon gene fusions, somatic mutations, and altered protein turnover in several tumours. Testicular germ cell tumours are among the most common malignancies in young males. Despite the high cure rate, achieved through chemotherapy and/or surgery, drug resistance can still occur. In a human cellular model of testis Embryonal Carcinoma, the deficiency of CCDC6 was associated with defects in DNA repair via homologous recombination and sensitivity to PARP1/2 inhibitors. Same data were obtained in a panel of murine testicular cell lines, including Sertoli, Spermatogonia and Spermatocytes. In these cells, upon oxidative damage exposure, the absence of CCDC6 conferred tolerance to reactive oxygen species affecting regulated cell death pathways by apoptosis and ferroptosis. At molecular level, the loss of CCDC6 was associated with an enhancement of the xCT/SLC7A11 cystine antiporter expression which, by promoting the accumulation of ROS, interfered with the activation of ferroptosis pathway. In conclusion, our data suggest that the CCDC6 downregulation could aid the testis germ cells to be part of a pro-survival pathway that helps to evade the toxic effects of endogenous oxidants contributing to testicular neoplastic growth. Novel therapeutic options will be discussed. Abstract : Seminoma; Embryonal carcinoma; DNA DSBs; Homologous recombination; PARP inhibitors; Deferoxamine; Ferrostatin-1; xCT/SLC7A11 cystine antiporter; Erastin; Targeted therapies; Glutathione